Please use this identifier to cite or link to this item:
https://doi.org/10.1038/s41467-023-37223-3
DC Field | Value | |
---|---|---|
dc.title | Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities | |
dc.contributor.author | Ho, Teresa Lai Fong | |
dc.contributor.author | Lee, May Yin | |
dc.contributor.author | Goh, Hui Chin | |
dc.contributor.author | Ng, Germaine Yi Ning | |
dc.contributor.author | Lee, Jane Jia Hui | |
dc.contributor.author | Kannan, Srinivasaraghavan | |
dc.contributor.author | Lim, Yan Ting | |
dc.contributor.author | Zhao, Tianyun | |
dc.contributor.author | Lim, Edwin Kok Hao | |
dc.contributor.author | Phua, Cheryl Zi Jin | |
dc.contributor.author | Lee, Yi Fei | |
dc.contributor.author | Lim, Rebecca Yi Xuan | |
dc.contributor.author | Ng, Perry Jun Hao | |
dc.contributor.author | Yuan, Ju | |
dc.contributor.author | Chan, Dedrick Kok Hong | |
dc.contributor.author | Lieske, Bettina | |
dc.contributor.author | Chong, Choon Seng | |
dc.contributor.author | Lee, Kuok Chung | |
dc.contributor.author | Lum, Jeffrey | |
dc.contributor.author | Cheong, Wai Kit | |
dc.contributor.author | Yeoh, Khay Guan | |
dc.contributor.author | Tan, Ker Kan | |
dc.contributor.author | Sobota, Radoslaw M | |
dc.contributor.author | Verma, Chandra S | |
dc.contributor.author | Lane, David P | |
dc.contributor.author | Tam, Wai Leong | |
dc.contributor.author | Venkitaraman, Ashok R | |
dc.date.accessioned | 2023-03-30T02:08:52Z | |
dc.date.available | 2023-03-30T02:08:52Z | |
dc.date.issued | 2023-03-28 | |
dc.identifier.citation | Ho, Teresa Lai Fong, Lee, May Yin, Goh, Hui Chin, Ng, Germaine Yi Ning, Lee, Jane Jia Hui, Kannan, Srinivasaraghavan, Lim, Yan Ting, Zhao, Tianyun, Lim, Edwin Kok Hao, Phua, Cheryl Zi Jin, Lee, Yi Fei, Lim, Rebecca Yi Xuan, Ng, Perry Jun Hao, Yuan, Ju, Chan, Dedrick Kok Hong, Lieske, Bettina, Chong, Choon Seng, Lee, Kuok Chung, Lum, Jeffrey, Cheong, Wai Kit, Yeoh, Khay Guan, Tan, Ker Kan, Sobota, Radoslaw M, Verma, Chandra S, Lane, David P, Tam, Wai Leong, Venkitaraman, Ashok R (2023-03-28). Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities. Nature Communications 14 (1). ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-023-37223-3 | |
dc.identifier.issn | 2041-1723 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/238519 | |
dc.description.abstract | <jats:title>Abstract</jats:title><jats:p>Mis-sense mutations affecting <jats:italic>TP53</jats:italic> promote carcinogenesis both by inactivating tumor suppression, and by conferring pro-carcinogenic activities. We report here that p53 DNA-binding domain (DBD) and transactivation domain (TAD) mis-sense mutants unexpectedly activate pro-carcinogenic epidermal growth factor receptor (EGFR) signaling via distinct, previously unrecognized molecular mechanisms. DBD- and TAD-specific <jats:italic>TP53</jats:italic> mutants exhibited different cellular localization and induced distinct gene expression profiles. In multiple tissues, EGFR is stabilized by TAD and DBD mutants in the cytosolic and nuclear compartments respectively. TAD mutants promote EGFR-mediated signaling by enhancing EGFR interaction with AKT via DDX31 in the cytosol. Conversely, DBD mutants maintain EGFR activity in the nucleus, by blocking EGFR interaction with the phosphatase SHP1, triggering c-Myc and Cyclin D1 upregulation. Our findings suggest that p53 mutants carrying gain-of-function, mis-sense mutations affecting two different domains form new protein complexes that promote carcinogenesis by enhancing EGFR signaling via distinctive mechanisms, exposing clinically relevant therapeutic vulnerabilities.</jats:p> | |
dc.publisher | Springer Science and Business Media LLC | |
dc.source | Elements | |
dc.type | Article | |
dc.date.updated | 2023-03-29T08:22:23Z | |
dc.contributor.department | BIOLOGY (NU) | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.contributor.department | BIOCHEMISTRY | |
dc.contributor.department | MICROBIOLOGY AND IMMUNOLOGY | |
dc.contributor.department | ORTHOPAEDIC SURGERY | |
dc.contributor.department | PATHOLOGY | |
dc.contributor.department | SURGERY | |
dc.contributor.department | MEDICINE | |
dc.description.doi | 10.1038/s41467-023-37223-3 | |
dc.description.sourcetitle | Nature Communications | |
dc.description.volume | 14 | |
dc.description.issue | 1 | |
dc.published.state | Unpublished | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Domain specific p53 mutants activate egfr by distinct mechanisms exposing tissue independent therapeutic vulnerabilities.pdf | Published version | 3.74 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.